Literature DB >> 33917818

Impact of Breast Size on Dosimetric Indices in Proton Versus X-ray Radiotherapy for Breast Cancer.

Lisa Cunningham1, Scott Penfold1, Eileen Giles2, Hien Le1,2, Michala Short2.   

Abstract

Deep inspiration breath hold (DIBH) radiotherapy is a technique used to manage early stage left-sided breast cancer. This study compared dosimetric indices of patient-specific X-ray versus proton therapy DIBH plans to explore differences in target coverage, radiation doses to organs at risk, and the impact of breast size. Radiotherapy plans of sixteen breast cancer patients previously treated with DIBH radiotherapy were re-planned with hybrid inverse-planned intensity modulated X-ray radiotherapy (h-IMRT) and intensity modulated proton therapy (IMPT). The total prescribed dose was 40.05 Gy in 15 fractions for all cases. Comparisons between the clinical, h-IMRT, and IMPT evaluated doses to target volumes, organs at risk, and correlations between doses and breast size. Although no differences were observed in target volume coverage between techniques, the h-IMRT and IMPT were able to produce more even dose distributions and IMPT delivered significantly less dose to all organs at risk than both X-ray techniques. A moderate negative correlation was observed between breast size and dose to the target in X-ray techniques, but not IMPT. Both h-IMRT and IMPT produced plans with more homogeneous dose distribution than forward-planned IMRT and IMPT achieved significantly lower doses to organs at risk compared to X-ray techniques.

Entities:  

Keywords:  breast cancer; breast size; intensity-modulated radiotherapy; precision medicine; proton therapy; radiotherapy planning

Year:  2021        PMID: 33917818     DOI: 10.3390/jpm11040282

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  1 in total

1.  The Role of Radiation in Cancer Treatment: New Insights towards Personalized Therapies.

Authors:  Luigi Minafra; Francesco P Cammarata; Marco Calvaruso
Journal:  J Pers Med       Date:  2022-02-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.